AI Model Predicts Cancer Treatment Response from Tumor Genotype - Genetic Engineering and Biotechnology News
Oh, marvellous. Another AI model that promises to revolutionise cancer treatment, because clearly the bottleneck in oncology has been a lack of predictive algorithms. Researchers at UC San Diego have unveiled a model that translates a tumor's genetic profile into predictions about treatment response, published in the hallowed pages of Cancer Discovery. One imagines the press release practically wrote itself: "AI will cure cancer" — never mind that the model's actual clinical utility remains a distant mirage on a crumbling road of regulatory approval and insurance reimbursement. The study will no doubt be cited by every AI-in-medicine startup seeking funding, while the clinicians who actually treat patients will continue to rely on their 40-year-old chemotherapeutic regimens.
The study involved training on some dataset of questionable generalisability, producing impressive AUCs that will never see the light of a real hospital. Because the gap between a published paper and a deployed clinical tool is not a gap — it's a chasm filled with FDA denials, hospital IT nightmares, and the quiet desperation of oncologists who have seen this movie before. But don't let that dampen the headlines. UC San Diego has spoken, and the future is here. Again. The model may be able to predict which drugs work on which tumors, but it cannot predict its own journey through the American healthcare system — a system that rewards innovation theatre over actual patient outcomes.
So raise a glass to yet another AI "breakthrough" that will generate a flurry of breathless coverage, a few grant renewals, and exactly zero changes in how cancer is treated this decade. Every few months, another group publishes a model that claims to predict treatment response with remarkable accuracy. Each time, the oncology community yawns and returns to the slow, messy work of evidence accumulation. This model will be no different. It will be validated on retrospective data, implemented at exactly one academic centre, and eventually forgotten when the next shiny AI object appears. Cheers to progress.